|
C12ORF66 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.402640E-04 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.593650E-02 |
| Normal-vs-Stage2 |
2.958400E-01 |
| Normal-vs-Stage3 |
5.53019999999238E-05 |
| Normal-vs-Stage4 |
5.59909999999775E-05 |
| Stage1-vs-Stage2 |
7.906200E-01 |
| Stage1-vs-Stage3 |
2.208100E-02 |
| Stage1-vs-Stage4 |
9.502900E-03 |
| Stage2-vs-Stage3 |
8.726000E-02 |
| Stage2-vs-Stage4 |
5.194000E-02 |
| Stage3-vs-Stage4 |
5.860000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.756300E-04 |
| Normal-vs-AfricanAmerican |
2.16049999999246E-05 |
| Normal-vs-Asian |
7.702000E-01 |
| Caucasian-vs-AfricanAmerican |
3.477600E-02 |
| Caucasian-vs-Asian |
5.045600E-01 |
| AfricanAmerican-vs-Asian |
9.808100E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.400540E-04 |
| Normal-vs-Female |
4.582000E-03 |
| Male-vs-Female |
4.211000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.864200E-03 |
| Normal-vs-Age(41-60Yrs) |
2.395500E-03 |
| Normal-vs-Age(61-80Yrs) |
4.388200E-04 |
| Normal-vs-Age(81-100Yrs) |
2.430000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.966600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.071600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.031600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.199400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.321600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.704800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.825200E-01 |
| Normal-vs-Grade 2 |
2.577900E-02 |
| Normal-vs-Grade 3 |
3.441500E-04 |
| Normal-vs-Grade 4 |
1.99602999999549E-05 |
| Grade 1-vs-Grade 2 |
8.506000E-01 |
| Grade 1-vs-Grade 3 |
4.748600E-01 |
| Grade 1-vs-Grade 4 |
1.340610E-01 |
| Grade 2-vs-Grade 3 |
1.337600E-01 |
| Grade 2-vs-Grade 4 |
4.838800E-03 |
| Grade 3-vs-Grade 4 |
8.510100E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.016600E-01 |
| Normal-vs-ccB subtype |
1.604720E-03 |
| ccA subtype-vs-ccB subtype |
3.336000E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.044050E-02 |
| Normal-vs-N1 |
5.527500E-02 |
| N0-vs-N1 |
2.564800E-01 |
|
|
